The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Apr. 25, 2017
Filed:
Oct. 30, 2012
Applicant:
Xenon Pharmaceuticals Inc., Burnaby, CA;
Inventors:
Shaoyi Sun, Burnaby, CA;
Alla Yurevna Zenova, Burnaby, CA;
Mikhail Chafeev, Burnaby, CA;
Qi Jia, Burnaby, CA;
Zaihui Zhang, Burnaby, CA;
Renata Marcella Oballa, Burnaby, CA;
Assignee:
XENON PHARMACEUTICALS INC., Burnaby, BC, CA;
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07D 417/12 (2006.01); C07D 239/42 (2006.01); C07D 285/08 (2006.01); C07D 401/12 (2006.01); C07D 413/12 (2006.01); C07D 211/22 (2006.01); C07D 257/06 (2006.01); C07D 261/14 (2006.01); C07D 277/52 (2006.01); C07D 285/135 (2006.01);
U.S. Cl.
CPC ...
C07D 239/42 (2013.01); C07D 211/22 (2013.01); C07D 257/06 (2013.01); C07D 261/14 (2013.01); C07D 277/52 (2013.01); C07D 285/08 (2013.01); C07D 285/135 (2013.01); C07D 401/12 (2013.01); C07D 413/12 (2013.01); C07D 417/12 (2013.01);
Abstract
This invention is directed to benzensulfonamide compounds, as stereoisomers, enantiomers, tautomers thereof or mixtures thereof; or pharmaceutically acceptable salts, solvates or prodrugs thereof, for the treatment of sodium channel-mediated diseases or conditions, such as pain.